Gliclazide is an anti-diabetic medication used to treat diabetes mellitus type 2.It is used when diet, exercise, and weight reduction have not been found to control blood glucose well enough without medication. Gliclazide increases the amount of insulin released by the pancreas and helps the body use insulin more efficiently.
Our company produces Gliclazide API and Gliclazide intermediates as below:
| Product Name | CAS No. |
| Gliclazide | 21187-98-4 |
| Cis-1,2-Cyclopentanedicarboxylic acid | N/A |
| 3-azabicyclo[3.3.0]octane hydrochloride | 112626-50-3 |
| N-Amino-3-azabicyclo[3.3.0]octane hydrochloride | 58108-05-7 |
By the way, our company will take part in CPhI China 2017, the 17th China Pharmaceutical Fair, which will take place at Shanghai New International Expo Centre (SNIEC), China during June 20 - 22, 2017. And our exhibition number is W3H32.Welcome to join us !